John advises healthcare and life sciences companies on M&A, licensing and financial strategy. He also speaks frequently on topics in valuation, deal term benchmarking, and exit strategy.
WaveEdge Capital is a healthcare investment bank advising companies across the healthcare space. Prior to forming WaveEdge, John was a Managing Director at Woodside Capital Partners, a boutique investment bank and co-led the Healthcare Group. For the prior 12 years, he advised both Fortune 100 and VC-backed healthcare companies on transaction strategy and valuation at Strategic Decisions Group (SDG), a global management consulting firm, and Keelin Reeds Partners, a life sciences and healthcare management consulting firm. While at Keelin Reeds, John led a partnership and M&A deal term benchmarking effort and has extensive experience in applying that data to yield market-value deal terms for dozens of assets, using the results to provide ongoing support during deal negotiations. Prior to consulting, John was an attorney with Weil, Gotshal and Manges LLP where he focused on M&A and corporate finance.
John holds a JD from Stanford Law School, where he was an Associate Editor of the Law Review, and a BA, magna cum laude, from Brown University, where he was a member of Phi Beta Kappa. (FINRA 24, 63, 79)